Nanotechnology could help fight diabetes
Injectable nanoparticles developed at Massachusetts Institute of Technology (MIT) may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. The nanoparticles weAstraZeneca issues update on accelerated oncology
AstraZeneca today announced that it will be moving three of its cancer compounds forward to Phase III
Aspirion Pharma has been geared to effectively leverage our specialist knowledge of tight markets to produce tangible results. We combine a proactive and entrepreneurial approach coupled with a developed methodology, which enables us to provide effective human capital solutions where others fail.
We have a 100% success rate for any retained assignments and we are determined to build upon this.
Therefore if you have a position which:
- Is difficult to fill
- The quality of the candidate cannot be compromised
- Sits within a competitive sector of the of the market




